5 Best Pharma Stocks to Buy Now

4. Pfizer Inc. (NYSE: PFE)

Number of Hedge Fund Holders: 63

Pfizer is getting a lot of attention since the company launched COVID-19 vaccine. The company is now moving forwarding with Phase 1 trials of its oral pill treatment for COVID-19.

However, Pfizer has much more than just the coronavirus vaccines. Earlier in March, Goldman Sachs named Pfizer one of its top pharma picks for 2021, as the firm believes big pharma companies with huge piles of cash are set to drive M&A activity in 2021.

Diamond Hill Capital currently owns 9.2 million shares of PFE, worth $337.9 million. Pfizer occupies 1.59% of Diamond Hill Capital’s overall equity.